LATEST
Feb 8, 2022
Gala Therapeutics Announces First Commercial Cases Worldwide with RheOx® System for Chronic Bronchitis
RheOx targets challenging cough and mucus symptoms by delivering non-thermal pulsed energy to the airways
San Carlos, Calif., February 8, 2022 – Gala Therapeutics, Inc. (Gala), a developer of medical devices to...